Fluid Biomed

Calgary, Canada

Fluid Biomed is a clinical stage medical device company that develops polymer-based brain stent to cure aneurysms.

$27.0M raised

Dec 2024

Series A

Top Investors

Amino CapitalShangbay CapitalCreative Destruction Lab (CDL)Amplitude Venture CapitalIAG Capital Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Fluid Biomed raised?

Fluid Biomed has raised $27.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.

Who are Fluid Biomed's investors?

Fluid Biomed's investors include Amino Capital, Shangbay Capital, Creative Destruction Lab (CDL), Amplitude Venture Capital, IAG Capital Partners.

Where is Fluid Biomed headquartered?

Fluid Biomed is headquartered in Calgary, Canada.

What does Fluid Biomed do?

Fluid Biomed is a clinical stage medical device company that develops polymer-based brain stent to cure aneurysms.

What stage is Fluid Biomed at?

Fluid Biomed is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 16, 2024.

MLA

"Fluid Biomed — Funding & Investors." VCBacked, December 16, 2024, https://www.vcbacked.co/company/fluid-biomed. Accessed June 8, 2026.

APA

VCBacked. (2024). Fluid Biomed — Funding & Investors. Retrieved June 8, 2026, from https://www.vcbacked.co/company/fluid-biomed

Wikipedia (cite web)

{{cite web |title=Fluid Biomed — Funding & Investors |url=https://www.vcbacked.co/company/fluid-biomed |website=VCBacked |access-date=June 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 16, 2024.